Dr. David Burks

After graduating from the University of Leeds, Dr. Ghani completed basic surgical training in Edinburgh followed by urological surgery training in London. He was awarded a Master of Surgery thesis from the University of London for research on percutaneous renal stone surgery. Following completion of sub-specialist training in Endourology at the Stone Unit at Guy’s Hospital, London, Dr. Ghani was awarded The Urology Foundation Scholarship and undertook fellowship training in robotic surgery at the Vattikuti Urology Institute, Henry Ford Hospital, Detroit.He joined the University of Michigan in 2013 and leads the Endourology program at the Ann Arbor VA Healthcare System. He treats patients with kidney problems: stones, cancer and obstruction. Dr Ghani has authored over 200 peer-reviewed articles, and his research focuses on endoscopic stone surgery and quality improvement. Specifically, he has been advancing a Dusting technique for ureteroscopy and has extramural funding to study laser lithotripsy in the laboratory. He is the Course Director of the annual Developments in Ureteroscopic Stone Treatment (D.U.S.T.) symposium, an international meeting that has exposed hundreds of urologists to advanced ureteroscopy techniques. He is also the Course Director of the American Urological Association annual course, Dust or Bust.In addition, Dr Ghani serves as the Director of the Michigan Urological Surgery Improvement Collaborative (MUSIC), which is a consortium of 46 urology practices aiming to improve the quality of care for patients with prostate cancer, kidney stones, and kidney cancer. Within MUSIC, he is the principal investigator of two randomized clinical trials assessing patient health-related quality of life and healthcare use after ureteroscopy. Dr. Ghani has received numerous prizes for his presentations and research from the American Urological Association, Endourological Society, European Association of Urology, and has lectured and taught surgeons throughout the world. He is an Assistant Editor for the Journal of Urology and serves on the editorial board of Nature Reviews Urology. Dr. Ghani is highly rated in 31 conditions, according to our data. His top areas of expertise are Kidney Stones, Urinary Tract Infection (UTI), Prostate Cancer, Lithotripsy, and Ureteroscopy.

Dr. Dauw received his medical degree from Loyola University in Chicago graduating Magna Cum Laude. He then completed a urology residency at The University of Michigan. Following this, he pursued subspecialty training in endourology with Dr. James Lingeman at Methodist Hospital in Indianapolis. His primary clinical interests include the medical and surgical management of kidney stones, in particular, endourological management of complex renal calculi. He is also one of few U.S. providers with expertise in holmium laser enucleation of the prostate (HoLEP), a state-of-the-art, minimally invasive surgical treatment for men with an enlarged prostate. His research interests focus on improving the quality of care for patients with kidney stones as well as understanding outcomes associated with commonly performed endourological surgeries. Dr. Dauw is highly rated in 16 conditions, according to our data. His top areas of expertise are Kidney Stones, Perirenal Abscess, Folliculitis, Ureteroscopy, and Lithotripsy.

Todd M. Morgan, M.D. is a urological surgeon specializing in the treatment of genitourinary malignancies. Dr. Morgan is originally from Seattle, WA, and completed his undergraduate and medical training at Harvard University. He returned to the Northwest in 2003 for his urology residency at the University of Washington, before moving to Nashville for his fellowship training in urological oncology at Vanderbilt University. Dr. Morgan is a translational surgeon-scientist, and his research spans the spectrum from preclinical laboratory-based research to prospective clinical trials. The primary focus of his laboratory is on identifying key pathways that predict response and resistance to treatment in genitourinary malignancies. This includes work in prostate cancer to develop liquid biopsy approaches that can guide precision-based therapeutic strategies in real time, as well as ongoing research in renal cell carcinoma to identify genomic signatures for risk stratification.Dr. Morgan is currently an Associate Professor of Urology and has been at the University of Michigan since 2012. In addition to his research pursuits, he is a busy clinician and surgeon offering advanced robotic, laparoscopic, and open surgical approaches for patients with genitourinary malignancies. He has substantial expertise in the use and interpretation of molecular biomarkers, which can help guide individualized treatment choice for some patients.Beyond work, he loves his time enjoying the great town of Ann Arbor and beautiful state of Michigan with his wife, Wendy, and their two young boys. Whether camping in Petoskey, sitting on a beach in Grand Haven, or biking around the neighborhood in Ann Arbor, the Morgan family has quickly learned that life in the Midwest is hard to beat. Dr. Morgan is highly rated in 20 conditions, according to our data. His top areas of expertise are Prostate Cancer, Muscle Invasive Bladder Cancer, Bladder Cancer, Prostatectomy, and Nephrectomy.